Agilon Health, Inc. (AGL)
$
0.83
Key metrics
Financial statements
Free cash flow per share
-0.2377
Market cap
343.2 Million
Price to sales ratio
0.0583
Debt to equity
0.1213
Current ratio
1.0792
Income quality
0.2232
Average inventory
0
ROE
-0.7312
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Agilon Health, Inc. specializes in providing healthcare services for seniors in communities across the United States through primary care physicians. As of December 31, 2021, the company served approximately 238,000 senior members, which included 186,300 Medicare Advantage members and 51,700 Medicare fee-for-service beneficiaries. The company recorded an operating income of -$292,130,000.00 reflecting its earnings from core operations. Additionally, the total costs and expenses for the company are $6,352,660,000.00 reflecting its overall spending. The net total of other income and expenses is $43,304,000.00 reflecting non-core financial activities. The EBITDA is -$218,186,000.00 a key indicator of the company's operational profitability. Furthermore, the weighted average number of diluted shares outstanding is $410,966,000.00 reflecting potential dilution effects. Agilon Health, Inc., which was formerly known as Agilon Health Topco, Inc. until March 2021, was founded in 2016 and is based in Austin, Texas. In the financial market, the stock is affordable at $1.16 making it suitable for budget-conscious investors. Furthermore, the stock has a high average trading volume of $8,799,798.00 indicating strong liquidity. With a market capitalization of $343,232,110.00 the company is classified as a small-cap player, which can provide unique opportunities for growth. It is a key player in the $Medical - Care Facilities industry, contributing significantly to the overall market landscape. Moreover, it belongs to the $Healthcare sector, driving innovation and growth within its market niche. Together, these attributes highlight the company's standing and potential for investors seeking involvement in the healthcare sector focused on senior care.
Is Agilon Health, Inc. (AGL) a good investment?
Investing in Agilon Health, Inc. (AGL) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C, with a Bearish outlook. Always conduct your own research before investing.
What is Agilon Health, Inc. (AGL)'s stock forecast?
Analysts predict Agilon Health, Inc. stock to fluctuate between $0.51 (low) and $6.08 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Agilon Health, Inc.'s market capitalization?
As of 2026-02-03, Agilon Health, Inc.'s market cap is $343,232,110, based on 414,581,604 outstanding shares.
How does Agilon Health, Inc. compare to competitors like Meta Platforms, Inc. Class A Common Stock?
Compared to Meta Platforms, Inc. Class A Common Stock, Agilon Health, Inc. has a Lower Market-Cap, indicating a difference in performance.
Does Agilon Health, Inc. pay dividends?
Agilon Health, Inc. pays dividends. The current dividend yield is 5.81%, with a payout of $0.45 per share.
How can I buy Agilon Health, Inc. (AGL) stock?
To buy Agilon Health, Inc. (AGL) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for AGL. Place an order (Market, Limit, etc.).
What is the best time to invest in Agilon Health, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
How did Agilon Health, Inc. perform in the last earnings report?
Revenue: $6,060,530,000 | EPS: -$0.63 | Growth: -1.56%.
Where can I find Agilon Health, Inc.'s investor relations reports?
Visit https://agilonhealth.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Agilon Health, Inc.?
You can explore historical data from here
What is the all-time high and low for Agilon Health, Inc. stock?
All-time high: $38.47 (2021-09-02) | All-time low: $0.51 (2025-11-19).
What are the key trends affecting Agilon Health, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
globenewswire.com
NEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the “Class Period”), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
prnewswire.com
NEW YORK, Feb. 2, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the "Class Period"), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
globenewswire.com
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Agilon (AGL) To Contact Him Directly To Discuss Their Options
newsfilecorp.com
New York, New York--(Newsfile Corp. - February 2, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the "Class Period"), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
globenewswire.com
LOS ANGELES, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming March 2, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL) securities between February 26, 2025 and August 4, 2025, inclusive (the “Class Period”).
globenewswire.com
Agilon Health Shareholders Between February 26, 2025 and August 4, 2025 - Contact Bernstein Liebhard For More Information Regarding Shareholder Lawsuit
newsfilecorp.com
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In agilon health To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in agilon health between February 26, 2025 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - February 1, 2026) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against agilon health, inc.
globenewswire.com
NEW YORK, Jan. 31, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the “Class Period”), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
newsfilecorp.com
New York, New York--(Newsfile Corp. - January 30, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of agilon health, inc. (NYSE: AGL) between February 26, 2025 and August 4, 2025, both dates inclusive (the "Class Period"), of the important March 2, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
globenewswire.com
NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against agilon health, inc. (NYSE: AGL) and certain of its officers.
See all news
